Data / Form D filings / ORTHO REGENERATIVE TECHNOLOGIES INC.
ORTHO REGENERATIVE TECHNOLOGIES INC.: Form D filings
ORTHO REGENERATIVE TECHNOLOGIES INC., a biotechnology company in Kirkland, Quebec, Canada, filed 2 Form D notices with the SEC between 2017 and 2020. The latest, on October 15, 2020, reports $73,394 sold of a $73,394 offering to 2 investors.
Find out what ORTHO REGENERATIVE TECHNOLOGIES INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 16667 BOUL HYMUS, Kirkland, Quebec, Canada, H9H 4
- Phone
- (514) 693-8832
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Canada (Federal Level)
- Revenue range
- Not Applicable
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1723032
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 15, 2020 | New notice | $73,394 | $73,394 | $0 | 2 | Sep 1, 2020 | sec.gov |
| Nov 27, 2017 | New notice | $50,000 | $50,000 | $0 | 1 | Oct 31, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael Atkin | Director | |
| LeDuc Claude | Executive Officer, Director | |
| Steve Saviuk | Director | |
| Michael Buschmann | Director | |
| Caroline Hoemann | Director | |
| Tom ES Wright | Director | |
| Pierre ES Laurin | Director | |
| Brent ES Norton | Director | |
| Luc ES Mainville | Executive Officer | |
| Guy Paul ES Allard | Executive Officer |
Every Form D from the week of Oct 12, 2020 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what ORTHO REGENERATIVE TECHNOLOGIES INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.